Research Article
Discriminative and Quantitative Analysis of Antineoplastic Taxane Drugs Using a Handheld Raman Spectrometer
Table 2
Results coming from the validation of the Raman method developed to quantify taxane drugs in sodium chloride solution.
| | CBX | PCX | DCX |
| Range of linearity (mg/mL) | 0.175 – 0.30 | 0.57 – 1.20 | 0.40 – 1.00 | Slope | 1.0001 | 0.9598 | 0.9917 | Intercept | 7.10−6 | 0.0252 | 0.0048 | R2 | 0.9999 | 0.9598 | 0.9909 | LOQ (mg/mL) | 0.16 | 0.56 | 0.40 |
| Relative bias (%) | | | | Level 1 | 0.3 | 6.1 | −1.4 | Level 2 | −2.2 | 5.1 | −4.2 | Level 3 | −0.2 | −1.2 | −5.3 | Repeatability (RSD %) | | | | Level 1 | 7.6 | 2.6 | 3.2 | Level 2 | 2.5 | 1.7 | 2.3 | Level 3 | 5.4 | 1.7 | 1.6 | Intermediate precision (RSD %) | | | | Level 1 | 10.7 | 8.6 | 5.2 | Level 2 | 3.9 | 1.8 | 2.7 | Level 3 | 5.4 | 1.8 | 2.5 | β-Expectation tolerance limit (%) | | | | Level 1 | [−24.7;25.3] | [−22.8; 35.0] | [14.5; 11.7] | Level 2 | [−11.6; 7.2] | [1.5; 8.8] | [−9.8; 1.5] | Level 3 | [−10.8; 10.4] | [−4.7; 2.2] | [−11.1; 0.4] |
|
|